Skip to content

OLIMAR

Active Private limited companyfounded 2009active for 17 yearsChemin du Château 5, 1400 NivellesKBO/BCE: BE 0809.713.933
OLIMAR
Follow ReportCompare

Overview

Lifetime

17 annual accounts with figures on one time axis
peak €32,772 (2024)
€14,361▼ 56.2%
lowest -€11,248 (2018)
€6,187▼ 66.2%
peak €58,903 (2025)
€58,903▲ 3.9%
€26,121▼ 20.9%
Board2 names since 2023
2 directorsBRAIBANT Maryse and 1 other
Owners2 names in the annual accounts
  
Documentsfilings and deeds
16-10-202677 days late
2025abbreviated format
Gross margin from €32,772 to €14,361Result from €18,319 to €6,187Dividend €4,000Debts from €33,024 to €26,121Investments €12,505Cash from €35,445 to €20,798

Key points

from the 2025 annual accounts

Equity

€58,903 ▲ 3.9%
56,7172024+6,187Profit-4,000Dividend58,9032025

OLIMAR paid out €4,000 in dividends. That is 65% of the 2025 profit.

Investments

€12,505 7.2 × depreciation
20212022202320242025

Green is investment, beige is depreciation.

Filings

17 annual accounts 77 days
AprilJune31 JulyOctober2010201520202025

Latest accounts filed late: after the legal deadline.

Checked score

92
Excellent
Financially stronger than 45% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.3%▲ +0.1 percentage points vs 07-2025 09-2025: 0.4%▲ +0.1 percentage points vs 08-2025 10-2025: 0.6%▲ +0.2 percentage points vs 09-2025highest value 11-2025: 0.1%▼ -0.5 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.2%▲ +0.1 percentage points vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.2 percentage points vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026

Financial strength
Strong

94+6equity 69.3% of total assets
76-16short-term debt 17.6% · cash 24.5%
78-12return on assets 7.3%

Score breakdown

raises risk
Last filed accounts filed 77 days late; 2 of the last 3 accounts late
No registered site in the KBO
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 3.27, cash €20,798
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 57% of them on solvency, 57% on liquidity, 23% on profitability and 44% on growth.

The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 34,693 companies had the same profile as OLIMAR has now. Each dot stands for 87 companies, two years later.

95.3%
were still trading
3.9%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of OLIMAR itself: 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,693 companies, not a prediction for OLIMAR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €5,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 3.27 (3.31 in 2024), above the usual 1.5. Short-term debt is 17.6% and cash 24.5% of total assets. 30.7% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 77 days late; 2 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.27, cash €20,798
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
raises risk · 2025 accounts filed 77 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-10-2026, 77 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
77 days late
2024
69 days late
2023
30 days early
2022
1 day late
2021
47 days late
2020
60 days early
2019
18 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 12 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 September (4 of the last 5 accounts filed within 46 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

BM
BRAIBANT Maryse
Director
GO
GREISCH Olivier
Director
  • Maryse Braibant 50%annual accounts 2021
  • Olivier Greisch 50%annual accounts 2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0809713933
Reappointments: GREISCH Olivier (director) and BRAIBANT Maryse (director) “Toutes opérations se rapportant à l’exercice de la kinésithérapie et de la microkinésithérapie et à la mise en…” (deed in French) · General meeting of 27-11-2023 · Gazette deed
Incorporation published on 19-02-2009 · Gazette deed
All 26 events

Comparable companies

same main activity, similar in size and age
Company
OLIMAR Nivelles €85,024 €14,361 69.3% -
VALHANSEN Watermael-Boitsfort €94,638 €15,217 28.8% -
Dokter Janssens Jacques Hasselt €108,900 €12,445 43.4% -
DR. WAJER, GYNAECOLOOG Vilvoorde €109,058 €14,873 31.0% -
PSYCHIATRIE LEBRUN Woluwe-Saint-Lambert €120,798 €14,656 99.0% -
DR. S. VAN BOUWEL Stabroek €89,333 €18,969 84.2% -
Dr. EYKERMAN Magali Mons €81,778 €19,594 44.3% -

These companies have the same main activity as OLIMAR: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €81,800 and €121,000, founded between 2004 and 2012.

Official details

Source: KBO
Status
Active since 27-01-2009Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Financial year end
31 December
Peppol
Reachable since 01-04-2026
Company details

Annual accounts 2025

€14,361▼ 56.2%
≈ €96,000estimated
€6,187▼ 66.2%
€58,903▲ 3.9%
€85,024▼ 5.3%
Filing
Filed on 16-10-2026
Financials

Insights on OLIMAR

OLIMAR files the abbreviated format. That format states no turnover. The gross margin rose from €7,026 in 2009 to €14,361 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

abbreviated format, filed on 16-10-2026, 77 days late
€14,361
▼ 56.2%
€12,050
▼ 59.5%
€13,785
▼ 56.8%
€7,922
▼ 61.4%
69.3%
▲ 6.1 percentage points
3.27
▼ 0.04

Money flows

no detail for 2025

Balance sheet

balance sheet total €85,024 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

69.3%

Higher than 59% of 3,053 companies in 2025.

3.27

Higher than 59% of 2,997 companies in 2025.

7.3%

Higher than 29% of 3,009 companies in 2025.

OLIMAR Middle half of the sector 80% of the sector Abbreviated accounts in human health (NACE 86)

Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201120102009
Balance sheet: assets
20/58 85,02489,74166,99953,95359,66371,48588,24796,99071,17370,91655,06668,88352,42130,04326,22828,84123,419
21/28 35,92825,15925,94028,32337,26849,21259,27870,50032,16027,8806602631,1312,1866161,6041,334
22/27 35,81825,04925,83028,21337,15849,10259,16870,39031,49027,2105501531,0212,0765061,4941,244
24 13,2741,3871,0502,3143,1781,184240452--5501531,0212,0765061,4941,244
25 ----6,964------------
26 22,54423,66224,78125,89927,01728,13529,25430,37231,49027,210-------
28 11011011011011011011011067067011011011011011011090
29/58 49,09664,58241,05925,63122,39522,27328,96926,49039,01343,03554,40668,62151,29027,85725,61227,23722,086
40/41 26,98529,13626,75817,2668,50115,21822,57718,05321,37326,46642,79355,61144,55321,60317,59219,44621,235
40 5,8288,7063,2003,4053,200-85----------
41 21,15720,43023,55813,8605,30115,21822,49218,05321,37326,46642,79355,61144,55321,60317,59219,44621,235
54/58 20,79835,4453,2533863,071011,39907236546999991
490/1 1,312-11,0477,98010,8237,0556,3917,03817,64016,49711,24812,5416,7286,2468,0117,782849
Balance sheet: equity and liabilities
10/49 85,02489,74166,99953,95359,66371,48588,24796,99071,17370,91655,06668,88352,42130,04326,22828,84123,419
10/15 58,90356,71738,39819,94818,56916,85118,41612,87624,12428,17026,78423,59422,83110,2918,2697,26310,511
10/11 8,0608,0608,0606,2008,0606,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,200
10 8,0608,060-6,200-------------
100 8,06020,460-18,600-18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
101 -12,400-12,400-12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
13 29,00029,00029,00020,86019,00020,86020,86020,86020,86020,86019,86015,86015,8601,8601,8601,8601,860
130/1 ---1,860-1,860-----------
130 ---1,860-1,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,860
133 29,00029,00029,00019,00019,00019,00019,00019,00019,00019,00018,00014,00014,000----
14 21,84319,6571,338-7,112-8,491-10,209-8,644-14,184-2,9361,1107241,5347712,231209-7972,451
17/49 26,12133,02428,60234,00641,09554,63469,83184,11447,04942,74628,28245,28929,59019,75317,95921,57812,908
17 11,12413,52115,55517,54026,03133,22043,58954,82626,75822,153-------
170/4 11,12413,52115,55517,54026,03133,22043,58954,82626,75822,153-------
42/48 14,99719,50413,04716,46615,06321,41326,24329,28820,13619,90928,28145,02529,37519,54417,77821,42612,908
42 5,1474,7844,73511,5599,45013,11814,20714,9434,4614,2814,9033,7747971,775---
43 -----3,4487,4016,9937,4196,6137,30814,7217,1316,7638,0294,9853,425
430/8 -----3,4487,4016,9937,4196,6137,30814,7217,1316,7638,0294,9853,425
44 1247972,4863,1464,7133,0912,8577,3527,5166,9816,91216,3967,9173,1803,4568,5134,369
440/4 1247972,4863,1464,7133,0912,8577,3527,5166,9816,91216,3967,9173,1803,4568,5134,369
45 5,72613,9235,8261,7628991,7551,777-7402,0342,78310,13413,5317,8276,2937,9295,114
450/3 5,36211,0065,8261,7628991,7551,777-7402,0342,78310,13413,5317,8276,2937,9295,114
454/9 3642,916---------------
47/48 4,000---------6,375------
492/3 --------1556841264214209181151-
Income statement
70 -204,065---------------
76A -------3,763---------
9900 14,36132,77221,53017,90022,28415,74625,2344,5612,32410,73212,675-47315,7672,934-1-1,5947,026
60/61 -171,293---------------
630 1,7362,1802,9769,8259,07111,56711,25011,4621,1181,4887038691,5131,8669881,267761
640/8 5758488119208066877801,2737907758081,8541,0649081,010990742
66A ------452400---------
9901 12,05029,74417,7437,15612,4073,49213,205-8,5754158,46911,164-3,19713,191160-1,999-3,8515,522
75/76B 70-11,6746226480045951452047112,0268,5838,0887,4325,9554,285
75 70-11,6746226480045951452047112,0268,5838,0887,4325,9554,285
65/66B 1,9922,2032,7032,5377,4382,4422,8262,5442,6513,9013,8873,7811,6381,6651,6071,855381
65 1,9922,2032,7032,5372,5862,4422,3742,5442,6513,9013,8873,7811,6381,6651,6071,855381
66B ----4,852-452----------
9903 10,12827,54026,7145,2415,6171,05010,378-10,660-1,7225,0897,7485,04920,1366,5833,8272499,426
67/77 3,9419,2218,2643,8623,8992,6144,8385882,3243,7034,5584,2867,5954,5612,8213,4975,114
9904 6,18718,31918,4501,3791,717-1,5645,540-11,248-4,0461,3863,19076212,5412,0221,006-3,2484,311
9905 6,18718,31918,4501,3791,717-1,5645,540-11,248-4,0461,3863,19076212,5412,0221,006-3,2484,311
Appropriation of the result
9906 25,84319,65711,338-7,112-8,491-10,209-8,644-14,184-2,9362,1104,7241,53414,7712,231209-7974,311
14P 19,6571,338-7,112-8,491-10,209------------
691/2 --10,000------1,0004,000-14,000---1,860
6920 ----------------1,860
6921 --10,000------1,0004,000-14,000----
694/7 4,000----------------
694 4,000----------------
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 16-10-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 77 days after the deadline. Filed on 16 October 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00560385.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 16-10-2026 2026-00560385 PDF
31-12-2024 micro format 08-10-2025 2025-00540980 PDF
31-12-2023 micro format 01-07-2024 2024-00205420 PDF
31-12-2022 micro format 01-08-2023 2023-00320276 PDF
31-12-2021 full format 16-09-2022 2022-20433384 PDF
31-12-2020 full format 01-06-2021 2021-17400138 PDF
31-12-2019 full format 13-07-2020 2020-30300409 PDF
31-12-2018 full format 06-08-2019 2019-44200594 PDF
31-12-2017 full format 31-07-2018 2018-42200435 PDF
31-12-2016 full format 28-08-2017 2017-49900206 PDF
31-12-2015 full format 01-07-2016 2016-26500019 PDF
31-12-2014 full format 09-10-2015 2015-64700334 PDF
31-12-2013 full format 31-10-2014 2014-66700531 PDF
31-12-2012 full format 02-10-2013 2013-62000264 PDF
31-12-2011 full format 25-07-2012 2012-35700392 PDF
31-12-2010 full format 04-08-2011 2011-38400566 PDF
31-12-2009 full format 24-08-2010 2010-48200018 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201120102009
13,78531,92420,71916,98121,47815,05924,4542,8871,5349,95811,867-2,32814,7042,026-1,011-2,5836,283
7,92220,49921,42611,20410,78810,00316,790214-2,9272,8743,8931,63114,0533,8881,994-1,9815,072
12,5051,3995948795,1791,50148056,5005,39828,7081,10004583,43601,5372,095
-14,64732,1922,868-2,6853,071-1-1,3981,399-72-292-1044600008-
34,09945,07828,0129,1657,3328602,726-2,79818,87723,12626,12523,59521,9148,3147,8345,8119,177
-14.6%---------------
69.3%63.2%57.3%37.0%31.1%23.6%20.9%13.3%33.9%39.7%48.6%34.3%43.6%34.3%31.5%25.2%44.9%
3.273.313.151.561.491.041.100.901.942.161.921.521.751.431.441.271.71
0.440.580.741.702.213.243.796.531.951.521.061.921.301.922.172.971.23
10.5%32.3%48.1%6.9%9.2%-9.3%30.1%-87.4%-16.8%4.9%11.9%3.2%54.9%19.6%12.2%-44.7%41.0%
7.3%20.4%27.5%2.6%2.9%-2.2%6.3%-11.6%-5.7%2.0%5.8%1.1%23.9%6.7%3.8%-11.3%18.4%
6.9214.497.666.698.30------------
-16 days---------------
-2 days---------------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€12,505€1,399€594€879€5,179
€1,736€2,180€2,976€9,825€9,071

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on OLIMAR

The operating result for 2025 is 59% lower than in 2024 and the lowest since 2022.

Debt's share of the balance-sheet total falls from 36.8% to 30.7%. Equity is higher and debt is lower.

Board & ownership

Board

2 directors
BRAIBANT Maryse
Director
in office according to the deed of 12-12-2023 term without a fixed end
GREISCH Olivier
Director
in office according to the deed of 12-12-2023 term without a fixed end

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
BRAIBANT Maryse
Director
GREISCH Olivier
Director
Boardmandate already running before its first mention
Mandates as a list
  • BRAIBANT Maryse
    • Director, since before 12-12-2023
  • GREISCH Olivier
    • Director, since before 12-12-2023

See the board, name and registered office on a given date →

Control

Shareholder
Maryse Braibant
50%
This company
OLIMAR
Equity €58,903
Profit €6,187 in 2025

and 1 other shareholder

Capital

Capital
€8,060
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Maryse Braibant
natural person
50%
50%
Olivier Greisch
natural person
50%
50%
Owners as a list

Older annual accounts also name 1 natural person.

Source: shareholder structure in its own accounts

Articles of association

deed of 12-12-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Thursday of June at 20:00

Shareholders

2 owners

Owners 2

Network & group

No group

OLIMAR has no parent and no holdings in its annual accounts.

Connections & network

2 current directors
Depth

The network starts from the directors of OLIMAR. Every other company they run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

26 events since 2009

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 77 days late
Registered in the Peppol Directory Reachable for e-invoices through 0208:0809713933
2025
Annual accounts 2024 filed PDFmicro format · 69 days late
2024
Annual accounts 2023 filed PDFmicro format · 30 days before the deadline
2023
Highest result from 2009 to 2025 net €18,450 ▲1,238% The net result of €18,450 is the highest of those years.
Liquidity doubles current ratio 3.15 The current ratio rises from 1.56 to 3.15. Short-term debt falls from €16,466 to €13,047.
Reappointments: GREISCH Olivier (director) and BRAIBANT Maryse (director)“Toutes opérations se rapportant à l’exercice de la kinésithérapie et de la microkinésithérapie et à la mise en…” (deed in French) · General meeting of 27-11-20235 points ▸
  • General meeting, 27-11-2023
  • Director reappointment, GREISCH Olivier
  • Director reappointment, BRAIBANT Maryse
  • Registered office clause, Chemin du Château 5, 1400 Nivelles
  • Power of attorney, Alexandra RHODIUS
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 1 day late
2022
Annual accounts 2021 filed PDFfull format · 47 days late
2021
Back to profit net €1,717 The net result is €1,717, after one loss-making year.
Annual accounts 2020 filed PDFfull format · 60 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 18 days before the deadline
2019
Back to profit net €5,540 The net result is €5,540, after 2 loss-making years.
Annual accounts 2018 filed PDFfull format · 6 days late
2018
Weakest financial year net -€11,248 The net result drops to -€11,248, the lowest from 2009 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFfull format · on the deadline day
2017
Annual accounts 2016 filed PDFfull format · 28 days late
2016
Annual accounts 2015 filed PDFfull format · 30 days before the deadline
2015
Annual accounts 2014 filed PDFfull format · 70 days late
2014
Annual accounts 2013 filed PDFfull format · 92 days late
2013
Annual accounts 2012 filed PDFfull format · 63 days late
2012
Annual accounts 2011 filed PDFfull format · 6 days before the deadline
2011
Back to profit net €1,006 The net result is €1,006, after one loss-making year.
Annual accounts 2010 filed PDFfull format · 4 days late
2010
Annual accounts 2009 filed PDFfull format · 24 days late
2009
Incorporation PDFpublished on 19-02-2009

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

OLIMAR was incorporated on 27 January 2009.1 The board currently has 2 members.2 Total assets fell from €96,990 in 2018 to €85,024 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 12-12-2023
  3. 3National Bank, annual accounts 2018 and 2025

Company details

Identity

Enterprise number
0809.713.933
VAT number
BE 0809.713.933
Peppol ID
0208:0809713933
Other Peppol ID
9925:BE0809713933
Legal form
Private limited company
Status
Active, normal situation
Founded
27-01-2009
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Thursday of June at 20:00
deed of 12-12-2023 (in French)
Peppol
Reachable since 01-04-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
OLIMAR in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 12-12-2023 (in French)

Activities

NACEBEL 2025
86220 Specialist medical practice main activity
86951 Physiotherapy
Codes under NACEBEL 2008
86220 Human health activities main activity
86905 Human health activities
PurposeThe purpose describes the activities the company may carry out under its articles.
“Toutes opérations se rapportant à l’exercice de la kinésithérapie et de la microkinésithérapie et à la mise en œuvres des techniques…”
9 activities
  1. Toutes opérations se rapportant à l’exercice de la kinésithérapie et de la microkinésithérapie et à la mise en œuvres des techniques kinésithérapeutiques ainsi que toutes disciplines apparentées et tous les types de soins en rapport avec la kinésithérapie, la réadaptation, la gymnastique médicale ainsi que tous les traitements de rééducation et de revalorisation des aptitudes physiques et éventuellement l’exploitation d’un centre ayant pour objet de fournir tous les soins que ces traitements exigent.
  2. La société pourra également avoir pour objet la constitution, la gestion et la valorisation d’un patrimoine mobilier et immobilier, notamment par l’achat, la vente, la location, la mise en location, la construction, le tout au sens le plus large.
  3. La société pourra louer ou sous louer, acquérir des droits réels ou la pleine propriété de tout immeuble dans le but soit d’y établir son siège, un siège d’exploitation ou d’y loger ses dirigeants et les membres de leur famille à titre de résidence principale.
  4. Elle dispose, d’une manière générale, d’une pleine capacité juridique pour accomplir tous les actes et opérations ayant un rapport direct ou indirect avec son objet ou qui seraient de nature à faciliter directement ou indirectement, entièrement ou partiellement, la réalisation de cet objet, y compris toute acquisition immobilière et autres nécessaire ou utile à la réalisation de l’objet.
  5. Elle peut s'intéresser par voie d'association, d'apport, de fusion, d'intervention financière ou autrement dans toutes sociétés, associations ou entreprises dont l'objet est identique, analogue ou connexe au sien ou susceptible de favoriser le développement de son entreprise ou de constituer pour elle une source de débouchés.
  6. La société peut se porter garant ou fournir des sûretés réelles pour des sociétés ou des personnes privées, au sens le plus large.
  7. La société pourra exercer toutes activités d’intermédiaire commercial dans les domaines ci-dessus énumérés et dans tous secteurs dont l’activité n’est pas réglementée à ce jour.
  8. La société peut constituer hypothèque ou toute autre sûreté réelle sur les biens sociaux ou se porter caution.
  9. Elle peut prêter à toutes sociétés et/ou personnes physiques et se porter caution pour elles, même hypothécairement.
deed of 12-12-2023 (in French)

Registered office and establishments

Chemin du Château 5 registered office 1400 Nivelles

Buildings and parcels at the address

Ground area
674 m²
Buildings
98 m²
Volume, LiDAR
595 m³
Tallest building
7.7 m
Buildings to scale, each on its own parcel
98 m², 7.7 m 98 m², 7.7 m

Location

exact location from the address register On OpenStreetMap

Parcels

Cadastral parcelArea Buildings Height / floors
25783F0440/00F000674 m² 1 · 98 m² 7.7 m · 2

We would like to set cookies. That happens only with your consent. What we measure